WIN2012 Symposium on Personalized Cancer Medicine Receives Endorsements from American Society of Clinical Oncology, ESMO, UICC and INCa

PARIS--(BUSINESS WIRE)--The upcoming annual symposium of the Worldwide Innovative Networking Consortium on personalized cancer medicine (WIN 2012), to be held in Paris, June 28-29, 2012, has received endorsements from the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO), the Union for International Cancer Control (UICC) and also the French national cancer institute (INCa).
MORE ON THIS TOPIC